Product Information
MIDODRINE HCL 2.5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0728 per EA under NDC 64980043301. Its NADAC has been published 339 times since Feb 26, 2020.
FDA first approved this application on Nov 2, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980043301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MIDODRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207613FDA Approved
11/2/2018
TE Code
AB
On Market Since
4/1/2019
Pharmacological Classes
Price Statistics
The NADAC for MIDODRINE HCL 2.5 MG TABLET has been published 339 times since Feb 26, 2020, and over the history we have for it it has declined 76.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0728 per EA |
|---|---|
| All-time high | $0.4071 (Apr 15, 2020) |
| All-time low | $0.0668 (Nov 20, 2024) |
| 52-week high | $0.0740 |
| 52-week low | $0.0703 |
| Median price | $0.1741 |
| Average price | $0.1651 |
| Largest weekly change | +59.2% (Nov 22, 2023) |
| Weeks tracked | 339 |
| Tracking since | Feb 26, 2020 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MIDODRINE HCL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIDODRINE HCL 2.5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0728 per EA (NDC 64980043301), effective Aug 19, 2026.
How has the price of MIDODRINE HCL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIDODRINE HCL 2.5 MG TABLET has declined 76.6%. It has been tracked across 339 weekly CMS publications since Feb 26, 2020.
What are the highest and lowest recorded NADAC prices for MIDODRINE HCL 2.5 MG TABLET?
Since Feb 26, 2020, the NADAC for MIDODRINE HCL 2.5 MG TABLET has ranged from a low of $0.0668 (Nov 20, 2024) to a high of $0.4071 (Apr 15, 2020), with a median of $0.1741 per EA.
Are there cheaper alternatives to MIDODRINE HCL 2.5 MG TABLET?
11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIDODRINE HCL 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MIDODRINE HCL 2.5 MG TABLET?
MIDODRINE HCL 2.5 MG TABLET (NDC 64980043301) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.